Eli Lilly and Co. has appointed Lucas Montarce as its new Chief Financial Officer, effective immediately. Montarce brings a wealth of experience from various leadership roles within the company, including international finance and pharmaceutical divisions. His appointment comes at a crucial time for Eli Lilly, which is navigating both significant growth in the weight loss market and regulatory hurdles for its Alzheimer’s drug. Montarce’s leadership will be key to managing these complexities and maintaining Lilly’s financial strength.